Table 5.
Protocol-Specified Adverse Events Related to Stereotactic Body Radiation Therapya
All Patients (n=55) |
First 49 Evaluable Patients (n=49) |
|||||
---|---|---|---|---|---|---|
Adverse Event | 3 | 4 | 5 | 3 | 4 | 5 |
| ||||||
Forced expiratory volume | 2 | 0 | 0 | 2 | 0 | 0 |
Hypocalcemia | 0 | 1 | 0 | 0 | 1 | 0 |
Hypoxia | 2 | 0 | 0 | 2 | 0 | 0 |
Pneumonitis NOS | 2 | 0 | 0 | 2 | 0 | 0 |
Pulmonary function test NOS decreased | 3 | 1 | 0 | 3 | 1 | 0 |
| ||||||
Maximum protocol-specific adverse event | 7 (13%) |
2 (4%) |
0 (0%) |
7 (14%) |
2 (4%) |
0 (0%) |
Includes adverse events where relationship to treatment is missing